Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) EBT Margin (2020 - 2025)

GeneDx Holdings has reported EBT Margin over the past 6 years, most recently at 15.07% for Q4 2025.

  • Quarterly results put EBT Margin at 15.07% for Q4 2025, down 2073.0% from a year ago — trailing twelve months through Dec 2025 was 4.94% (up 1229.0% YoY), and the annual figure for FY2025 was 4.94%, up 1229.0%.
  • EBT Margin for Q4 2025 was 15.07% at GeneDx Holdings, down from 6.33% in the prior quarter.
  • Over the last five years, EBT Margin for WGSWW hit a ceiling of 75.8% in Q3 2021 and a floor of 503.13% in Q4 2022.
  • Median EBT Margin over the past 5 years was 57.56% (2021), compared with a mean of 98.16%.
  • Biggest five-year swings in EBT Margin: crashed -43361bps in 2022 and later skyrocketed 45753bps in 2023.
  • GeneDx Holdings' EBT Margin stood at 69.52% in 2021, then crashed by -624bps to 503.13% in 2022, then surged by 91bps to 45.6% in 2023, then soared by 112bps to 5.66% in 2024, then crashed by -366bps to 15.07% in 2025.
  • The last three reported values for EBT Margin were 15.07% (Q4 2025), 6.33% (Q3 2025), and 10.29% (Q2 2025) per Business Quant data.